Logo image of PNOR.OL

PETRONOR E&P ASA (PNOR.OL) Stock Fundamental Analysis

OSL:PNOR - Euronext Oslo - NO0012942525 - Common Stock - Currency: NOK

11.3  0 (0%)

Fundamental Rating

7

Taking everything into account, PNOR scores 7 out of 10 in our fundamental rating. PNOR was compared to 60 industry peers in the Oil, Gas & Consumable Fuels industry. PNOR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PNOR is valued quite cheap, but it does not seem to be growing. This makes PNOR very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

PNOR had positive earnings in the past year.
In the past year PNOR had a positive cash flow from operations.
PNOR had positive earnings in each of the past 5 years.
PNOR had a positive operating cash flow in 4 of the past 5 years.
PNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFPNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.81%, PNOR is in the better half of the industry, outperforming 78.33% of the companies in the same industry.
PNOR has a Return On Equity (13.53%) which is comparable to the rest of the industry.
PNOR's Return On Invested Capital of 17.63% is amongst the best of the industry. PNOR outperforms 88.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PNOR is significantly above the industry average of 14.91%.
The last Return On Invested Capital (17.63%) for PNOR is well below the 3 year average (25.97%), which needs to be investigated, but indicates that PNOR had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROIC 17.63%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
PNOR.OL Yearly ROA, ROE, ROICPNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

PNOR has a Profit Margin of 13.40%. This is in the better half of the industry: PNOR outperforms 65.00% of its industry peers.
In the last couple of years the Profit Margin of PNOR has grown nicely.
PNOR has a better Operating Margin (41.83%) than 90.00% of its industry peers.
PNOR's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 49.30%, PNOR perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
PNOR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 41.83%
PM (TTM) 13.4%
GM 49.3%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
PNOR.OL Yearly Profit, Operating, Gross MarginsPNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PNOR is creating value.
PNOR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for PNOR has been reduced compared to 5 years ago.
PNOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNOR.OL Yearly Shares OutstandingPNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PNOR.OL Yearly Total Debt VS Total AssetsPNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.69 indicates that PNOR is not in any danger for bankruptcy at the moment.
PNOR has a better Altman-Z score (3.69) than 81.67% of its industry peers.
There is no outstanding debt for PNOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.69
ROIC/WACC2.04
WACC8.65%
PNOR.OL Yearly LT Debt VS Equity VS FCFPNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.97 indicates that PNOR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.97, PNOR belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
PNOR has a Quick Ratio of 3.53. This indicates that PNOR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.53, PNOR belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.53
PNOR.OL Yearly Current Assets VS Current LiabilitesPNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

The earnings per share for PNOR have decreased strongly by -75.12% in the last year.
The Earnings Per Share has been growing by 38.60% on average over the past years. This is a very strong growth
PNOR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.41%.
PNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.76% yearly.
EPS 1Y (TTM)-75.12%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-88.74%
Revenue 1Y (TTM)-49.41%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-68.56%

3.2 Future

PNOR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -41.61% yearly.
PNOR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.47% yearly.
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PNOR.OL Yearly Revenue VS EstimatesPNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PNOR.OL Yearly EPS VS EstimatesPNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

PNOR is valuated cheaply with a Price/Earnings ratio of 6.38.
Based on the Price/Earnings ratio, PNOR is valued cheaper than 83.33% of the companies in the same industry.
PNOR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
PNOR is valuated cheaply with a Price/Forward Earnings ratio of 7.29.
Based on the Price/Forward Earnings ratio, PNOR is valued a bit cheaper than 78.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, PNOR is valued rather cheaply.
Industry RankSector Rank
PE 6.38
Fwd PE 7.29
PNOR.OL Price Earnings VS Forward Price EarningsPNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PNOR indicates a rather cheap valuation: PNOR is cheaper than 98.33% of the companies listed in the same industry.
PNOR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PNOR is cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.36
EV/EBITDA 0.55
PNOR.OL Per share dataPNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of PNOR may justify a higher PE ratio.
PNOR's earnings are expected to decrease with -41.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PNOR!.
Industry RankSector Rank
Dividend Yield N/A

PETRONOR E&P ASA

OSL:PNOR (7/14/2025, 3:30:32 PM)

11.3

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20
Earnings (Next)08-20 2025-08-20
Inst Owners0.9%
Inst Owner ChangeN/A
Ins Owners2.25%
Ins Owner ChangeN/A
Market Cap1.61B
Analysts82.86
Price Target13.26 (17.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.38
Fwd PE 7.29
P/S 0.91
P/FCF 3.36
P/OCF 2.61
P/B 0.92
P/tB 0.97
EV/EBITDA 0.55
EPS(TTM)1.77
EY15.66%
EPS(NY)1.55
Fwd EY13.71%
FCF(TTM)3.36
FCFY29.73%
OCF(TTM)4.32
OCFY38.24%
SpS12.39
BVpS12.26
TBVpS11.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROCE 31.28%
ROIC 17.63%
ROICexc 32.75%
ROICexgc 35.01%
OM 41.83%
PM (TTM) 13.4%
GM 49.3%
FCFM 27.12%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
ROICexc(3y)33.15%
ROICexc(5y)39.25%
ROICexgc(3y)39.5%
ROICexgc(5y)46.11%
ROCE(3y)47.13%
ROCE(5y)55.34%
ROICexcg growth 3Y-21.92%
ROICexcg growth 5Y-46.42%
ROICexc growth 3Y-20.01%
ROICexc growth 5Y-37.94%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 67.35%
Cap/Sales 7.76%
Interest Coverage 224.83
Cash Conversion 65.38%
Profit Quality 202.47%
Current Ratio 3.97
Quick Ratio 3.53
Altman-Z 3.69
F-Score5
WACC8.65%
ROIC/WACC2.04
Cap/Depr(3y)235.93%
Cap/Depr(5y)264.03%
Cap/Sales(3y)18.03%
Cap/Sales(5y)16.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.12%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-88.74%
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.41%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-68.56%
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.3%
EBIT growth 3Y12.49%
EBIT growth 5Y13.46%
EBIT Next Year-7.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y385.71%
FCF growth 3YN/A
FCF growth 5Y9.26%
OCF growth 1Y22.93%
OCF growth 3Y50.47%
OCF growth 5Y7.36%